Retrophin to Present at Upcoming Investor Conferences
2020年11月12日 - 6:30AM
Retrophin, Inc. (NASDAQ: RTRX) today announced that Company
management will present at the following upcoming virtual investor
conferences in November and December:
Jefferies 2020
Virtual London Healthcare
ConferenceDate: Wednesday, November 18,
2020Time: 6:45 p.m. GMT (1:45 p.m. ET)
2020 Evercore ISI
Virtual HealthCONx
ConferenceDate: Tuesday, December
1, 2020Time: 1:25 p.m. ET
Live webcasts will be available at
http://ir.retrophin.com/events and archived replays will be
accessible for up to 30 days.
About Retrophin
Retrophin is a biopharmaceutical company
specializing in identifying, developing and delivering
life-changing therapies to people living with rare disease. The
Company’s approach centers on its pipeline featuring sparsentan, a
product candidate in late-stage development for focal segmental
glomerulosclerosis (FSGS) and IgA nephropathy (IgAN), rare
disorders characterized by progressive scarring of the kidney often
leading to end-stage renal disease. Research in additional rare
diseases is also underway, including partnerships with leaders in
patient advocacy and government research to identify potential
therapeutics for NGLY1 deficiency and Alagille syndrome, conditions
with no approved treatment options. Retrophin’s R&D efforts are
supported by revenues from the Company’s commercial products
Chenodal®, Cholbam®, Thiola® and Thiola EC®.
Retrophin.com
Contact:
Chris Cline, CFASenior Vice President, Investor
Relations & Corporate
Communications888-969-7879IR@retrophin.com
Retrophin (NASDAQ:RTRX)
過去 株価チャート
から 8 2024 まで 9 2024
Retrophin (NASDAQ:RTRX)
過去 株価チャート
から 9 2023 まで 9 2024
Real-Time news about Retrophin Inc (ナスダック市場): 0 recent articles
その他のニュース記事